勃起功能障碍
人参
医学
传统医学
药理学
重症监护医学
替代医学
内科学
病理
作者
Amy Ting Shy Yee,Lee Tiong Chan
出处
期刊:OAlib
[Scientific Research Publishing]
日期:2021-01-01
卷期号:08 (10): 1-17
被引量:2
标识
DOI:10.4236/oalib.1108043
摘要
Early identification and treatment of erectile dysfunction (ED) and ED related comorbidities, including hypertension, diabetes mellitus, and hyperlipidemia is crucial in improving the quality of life of men and their partners.To date, the main treatment options for ED can be divided into pharmacological and surgical interventions.These treatments include oral phosphodiesterase type 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil), intraurethral or intracavernosal alprostadil, vacuum devices and penile prosthesis.Although considerable advances have been made, there seems to be a high dropout rate of the above treatment due to cultural restrictions and taboos.Subsequently, these patients would seek herbal dietary supplements such as ginseng as an alternative.Even though several studies have proved that ginseng is ideal in treating ED, the published trials on humans were not robust, and there is a lack of exploration of subjective outcomes.This literature review aimed to synthesize and critically appraise clinical and scientific literature on the effects of ginseng in managing ED.In total, 7 studies were included and reviewed.It was concluded that ginseng is a feasible alternative to currently available practices in treating ED due to a significant improvement in International Index of Erectile Function (IIEF)-5 scores and its safety profile.There is a higher likelihood to consider ginseng as an alternative therapy if more studies with larger-scaled clinical trials and higher standards on the safety and efficacy of ginseng are conducted in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI